The present
patent application is essentially characterized by a chemical formulation based on
papain,
urea,
zinc sulfate, and ubiquinol, the purpose of which is to treat and heal
skin affected by
melasma; composed of:
papain 10%;
urea 5%;
zinc sulfate 6%; ubiquinol 5%, in a
cream base ad 100g, wherein the preparation must be carried out by a person skilled in the art who is familiar with the chemical processes and the use of each composition for correct manipulation; a product for topical nighttime application, suitable for all
skin types; the area to be treated must be clean and dry, the formula applied to the
melasma area, once it is absorbed into the
skin, a sunscreen applied over it; the minimum
treatment duration should be 6 to 12 months;In this way, it is determined that this formulation combats
cell senescence, regenerates the
stratum corneum and the
phospholipid bilayer of cells, combats
lipid peroxidation and local
inflammation, eliminates excess free radicals from the
intracellular environment, reorganizes the structures of internal organelles, preserves
DNA integrity and maintains skin
homeostasis and health, healing, reducing dark spots, and making the skin healthier, softer, more radiant, and more moisturized.